Taylor Sandison - Sep 12, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Chief Medical Officer
Signature: /s/ Shane Ward, Attorney-in-Fact
Stock symbol: CDTX
Transactions as of: Sep 12, 2022
Transactions value $: -$12,656
Form type: 4
Date filed: 9/13/2022, 06:51 PM
Previous filing: Apr 4, 2022
Next filing: Mar 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Sale	-$12.7K	-18.5K	-5.96%	$0.68	292K	Sep 12, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2	Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.

Content

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.